Delayed puberty (no breasts at 13 years, no testicular enlargement at 14 years) and primary amenorrhoea
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
First-line tests
Laboratory tests in the morning (before 10 am)
- LH
- FSH
- Total testosterone (boy), in the morningif needednon-French guidelineIn boys: baseline testosterone is part of the initial screening; it follows a circadian rhythm and is measured in the morning [1].
- Oestradiol (girl)if needednon-French guidelineIn girls: a low oestradiol may suggest hypogonadism; a level > 50 pg/mL has been proposed to rule it out; sleep, diet, acute illness and assay technique alter the values, so no single threshold is validated [1].
- FBC
- CRP
- Serum creatinine with eGFR
- TSH
- Free T4 (state "looking for pituitary deficiency")
- IgA anti-tissue transglutaminase antibodies (tTG-IgA)if neededCoeliac disease screening is part of the initial tests proposed in the 2024 review [1]; NICE recommends it for slowing growth, digestive disorders, prolonged fatigue or weight loss [2], and the NABM reimburses it first-line when coeliac disease is suspected [3].
- Total IgAif neededCoeliac disease screening is part of the initial tests proposed in the 2024 review [1]; NICE recommends it for slowing growth, digestive disorders, prolonged fatigue or weight loss [2], and the NABM reimburses it first-line when coeliac disease is suspected [3].
- IGF-1 (if slowing of height growth)if needednon-French guidelineIGF-1 and prolactin are used to look for another pituitary deficiency [1]; a marked slowing of growth suggests growth hormone deficiency [1].
- Serum prolactin (if headache, visual disturbance, galactorrhoea, other pituitary sign)if needednon-French guidelineProlactin is among the assays proposed to rule out another pituitary deficiency, hyperprolactinaemia being a cause of functional delayed puberty [1].
- Serum electrolytesif needednon-French guidelineRenal and liver function and electrolytes are among the tests advised to rule out an underlying chronic disease [1].
- ASTif needednon-French guidelineRenal and liver function and electrolytes are among the tests advised to rule out an underlying chronic disease [1].
- ALTif needednon-French guidelineRenal and liver function and electrolytes are among the tests advised to rule out an underlying chronic disease [1].
- Blood karyotype (in a short girl or one with signs of Turner syndrome; signed consent form enclosed)if neededIn girls, the 2024 international Turner syndrome guideline asks for chromosome analysis for unexplained short stature, unexplained delayed puberty or suggestive signs, each sufficient on its own, counting at least 30 metaphases (expert consensus) [4]; the French PNDS also raises the syndrome in the adolescent girl with a height deficit ≤ -2 SD or no breast development after age 13 [5]. Without these signs, the karyotype is discussed after LH and FSH measurement (“High gonadotrophins” tab).
Imaging
- PA X-ray of the left hand and wrist (bone age).
Do not order
Primary amenorrhoea with breast development (no periods at 15 years)
Laboratory tests
- Serum β-hCG
- FSH
- Oestradiol
- TSH
- Serum prolactin
Imaging
- Pelvic ultrasound (presence of the uterus) if gynaecological examination is not feasible.
High gonadotrophins: hypergonadotropic hypogonadism (Turner, Klinefelter)
Laboratory tests
- LH
- FSH
- Blood karyotype (enclose the information and consent form signed by the holders of parental authority)
Low gonadotrophins: constitutional delay or gonadotropin deficiency
- No other laboratory tests in the community: opinion of a paediatric endocrinologist if any feature is atypical for simple delay or if puberty does not start during follow-up.
Sources (8)
- Abacı A, Besci Ö. A current perspective on delayed puberty and its management. J Clin Res Pediatr Endocrinol. 2024;16(4):379-400.
- National Institute for Health and Care Excellence. Coeliac disease: recognition, assessment and management. NICE guideline NG20, 2 septembre 2015.
- Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 1211 (TSH + T4 libre), 0901 (caryotype), 0777 (inhibines) et 1828 (anticorps antitransglutaminase IgA).
- Gravholt CH, Andersen NH, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome. Eur J Endocrinol. 2024;190:G53-G151.
- Centre de référence des maladies endocriniennes rares de la croissance et du développement. Syndrome de Turner. Protocole national de diagnostic et de soins (PNDS), Haute Autorité de santé, octobre 2021.
- Abitbol L, Zborovski S, Palmert MR. Evaluation of delayed puberty: what diagnostic tests should be performed in the seemingly otherwise well adolescent? Arch Dis Child. 2016;101(8):767-71.
- Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea: a committee opinion. Fertil Steril. 2024;122(1):52-61.
- Klein DA, Emerick JE, Sylvester JE, Vogt KS. Disorders of Puberty: An Approach to Diagnosis and Management. Am Fam Physician. 2017;96(9):590-599.